nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP3A4—prostate cancer	0.196	1	CbGaD
Perhexiline—CYP2B6—Estrone—prostate cancer	0.0555	0.118	CbGbCtD
Perhexiline—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0542	0.115	CbGbCtD
Perhexiline—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0495	0.105	CbGbCtD
Perhexiline—CYP2D6—Bicalutamide—prostate cancer	0.0448	0.0952	CbGbCtD
Perhexiline—CYP2D6—Abiraterone—prostate cancer	0.0371	0.0789	CbGbCtD
Perhexiline—CYP3A4—Bicalutamide—prostate cancer	0.0285	0.0606	CbGbCtD
Perhexiline—CYP3A4—Estramustine—prostate cancer	0.0265	0.0563	CbGbCtD
Perhexiline—CYP3A4—Abiraterone—prostate cancer	0.0236	0.0502	CbGbCtD
Perhexiline—CYP3A4—Flutamide—prostate cancer	0.0236	0.0502	CbGbCtD
Perhexiline—CYP3A4—Cabazitaxel—prostate cancer	0.0174	0.0371	CbGbCtD
Perhexiline—CYP3A4—Estrone—prostate cancer	0.017	0.0363	CbGbCtD
Perhexiline—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0152	0.0323	CbGbCtD
Perhexiline—CYP2B6—Doxorubicin—prostate cancer	0.0142	0.0302	CbGbCtD
Perhexiline—CYP3A4—Conjugated Estrogens—prostate cancer	0.0112	0.0237	CbGbCtD
Perhexiline—CYP3A4—Mitoxantrone—prostate cancer	0.0101	0.0216	CbGbCtD
Perhexiline—CYP3A4—Estradiol—prostate cancer	0.00979	0.0208	CbGbCtD
Perhexiline—CYP3A4—Prednisone—prostate cancer	0.00842	0.0179	CbGbCtD
Perhexiline—CYP2D6—Doxorubicin—prostate cancer	0.00686	0.0146	CbGbCtD
Perhexiline—CYP3A4—Etoposide—prostate cancer	0.00639	0.0136	CbGbCtD
Perhexiline—CYP3A4—Docetaxel—prostate cancer	0.00585	0.0124	CbGbCtD
Perhexiline—CPT1A—prostate gland—prostate cancer	0.00549	0.12	CbGeAlD
Perhexiline—CPT2—prostate gland—prostate cancer	0.00521	0.114	CbGeAlD
Perhexiline—CPT2—seminal vesicle—prostate cancer	0.00441	0.0964	CbGeAlD
Perhexiline—CYP3A4—Doxorubicin—prostate cancer	0.00436	0.00928	CbGbCtD
Perhexiline—CPT1A—renal system—prostate cancer	0.00374	0.0819	CbGeAlD
Perhexiline—CPT2—renal system—prostate cancer	0.00355	0.0777	CbGeAlD
Perhexiline—CPT2—urethra—prostate cancer	0.00349	0.0763	CbGeAlD
Perhexiline—CYP3A4—urine—prostate cancer	0.00285	0.0624	CbGeAlD
Perhexiline—CYP2D6—urine—prostate cancer	0.00281	0.0614	CbGeAlD
Perhexiline—CPT2—bone marrow—prostate cancer	0.00268	0.0587	CbGeAlD
Perhexiline—CPT1A—testis—prostate cancer	0.00242	0.0529	CbGeAlD
Perhexiline—CPT2—testis—prostate cancer	0.00229	0.0502	CbGeAlD
Perhexiline—CPT1A—lymph node—prostate cancer	0.00175	0.0384	CbGeAlD
Perhexiline—CPT2—lymph node—prostate cancer	0.00166	0.0364	CbGeAlD
Perhexiline—CYP2B6—renal system—prostate cancer	0.000924	0.0202	CbGeAlD
Perhexiline—CYP3A4—renal system—prostate cancer	0.000698	0.0153	CbGeAlD
Perhexiline—CYP2D6—renal system—prostate cancer	0.000687	0.015	CbGeAlD
Perhexiline—CYP2B6—testis—prostate cancer	0.000597	0.0131	CbGeAlD
Perhexiline—CYP2D6—testis—prostate cancer	0.000444	0.00971	CbGeAlD
Perhexiline—Hepatitis—Mitoxantrone—prostate cancer	0.000299	0.0022	CcSEcCtD
Perhexiline—Flushing—Estradiol—prostate cancer	0.000298	0.00219	CcSEcCtD
Perhexiline—Asthenia—Bicalutamide—prostate cancer	0.000297	0.00218	CcSEcCtD
Perhexiline—Diplopia—Capecitabine—prostate cancer	0.000289	0.00213	CcSEcCtD
Perhexiline—Nausea—Cabazitaxel—prostate cancer	0.000286	0.00211	CcSEcCtD
Perhexiline—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000286	0.0021	CcSEcCtD
Perhexiline—Gait disturbance—Epirubicin—prostate cancer	0.000285	0.0021	CcSEcCtD
Perhexiline—Shock—Goserelin—prostate cancer	0.000283	0.00208	CcSEcCtD
Perhexiline—Ataxia—Docetaxel—prostate cancer	0.000281	0.00207	CcSEcCtD
Perhexiline—Shock—Conjugated Estrogens—prostate cancer	0.00028	0.00206	CcSEcCtD
Perhexiline—Hyperhidrosis—Goserelin—prostate cancer	0.000278	0.00205	CcSEcCtD
Perhexiline—Hepatocellular injury—Epirubicin—prostate cancer	0.000278	0.00205	CcSEcCtD
Perhexiline—Urticaria—Ethinyl Estradiol—prostate cancer	0.000278	0.00204	CcSEcCtD
Perhexiline—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000276	0.00203	CcSEcCtD
Perhexiline—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000275	0.00203	CcSEcCtD
Perhexiline—Anorexia—Goserelin—prostate cancer	0.000274	0.00202	CcSEcCtD
Perhexiline—Tension—Estradiol—prostate cancer	0.000274	0.00202	CcSEcCtD
Perhexiline—Dizziness—Bicalutamide—prostate cancer	0.000273	0.00201	CcSEcCtD
Perhexiline—Ataxia—Capecitabine—prostate cancer	0.000272	0.002	CcSEcCtD
Perhexiline—Neuropathy peripheral—Etoposide—prostate cancer	0.000272	0.002	CcSEcCtD
Perhexiline—Anorexia—Conjugated Estrogens—prostate cancer	0.000272	0.002	CcSEcCtD
Perhexiline—Nervousness—Estradiol—prostate cancer	0.000271	0.002	CcSEcCtD
Perhexiline—Gait disturbance—Doxorubicin—prostate cancer	0.000263	0.00194	CcSEcCtD
Perhexiline—Vomiting—Bicalutamide—prostate cancer	0.000263	0.00194	CcSEcCtD
Perhexiline—Tremor—Estradiol—prostate cancer	0.000262	0.00193	CcSEcCtD
Perhexiline—Rash—Bicalutamide—prostate cancer	0.000261	0.00192	CcSEcCtD
Perhexiline—Dermatitis—Bicalutamide—prostate cancer	0.000261	0.00192	CcSEcCtD
Perhexiline—Insomnia—Goserelin—prostate cancer	0.00026	0.00192	CcSEcCtD
Perhexiline—Headache—Bicalutamide—prostate cancer	0.000259	0.00191	CcSEcCtD
Perhexiline—Paraesthesia—Goserelin—prostate cancer	0.000258	0.0019	CcSEcCtD
Perhexiline—Insomnia—Conjugated Estrogens—prostate cancer	0.000258	0.0019	CcSEcCtD
Perhexiline—Hepatocellular injury—Doxorubicin—prostate cancer	0.000257	0.00189	CcSEcCtD
Perhexiline—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000256	0.00188	CcSEcCtD
Perhexiline—Muscular weakness—Capecitabine—prostate cancer	0.000255	0.00188	CcSEcCtD
Perhexiline—Asthenia—Ethinyl Estradiol—prostate cancer	0.000251	0.00185	CcSEcCtD
Perhexiline—Syncope—Estradiol—prostate cancer	0.000251	0.00185	CcSEcCtD
Perhexiline—Decreased appetite—Goserelin—prostate cancer	0.00025	0.00184	CcSEcCtD
Perhexiline—Fatigue—Goserelin—prostate cancer	0.000248	0.00183	CcSEcCtD
Perhexiline—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000248	0.00182	CcSEcCtD
Perhexiline—Fatigue—Conjugated Estrogens—prostate cancer	0.000246	0.00181	CcSEcCtD
Perhexiline—Nausea—Bicalutamide—prostate cancer	0.000246	0.00181	CcSEcCtD
Perhexiline—Loss of consciousness—Estradiol—prostate cancer	0.000246	0.00181	CcSEcCtD
Perhexiline—Gastrointestinal pain—Goserelin—prostate cancer	0.000235	0.00173	CcSEcCtD
Perhexiline—Weight decreased—Docetaxel—prostate cancer	0.000234	0.00172	CcSEcCtD
Perhexiline—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000233	0.00172	CcSEcCtD
Perhexiline—Dizziness—Ethinyl Estradiol—prostate cancer	0.000231	0.0017	CcSEcCtD
Perhexiline—Flushing—Etoposide—prostate cancer	0.000231	0.0017	CcSEcCtD
Perhexiline—Urticaria—Goserelin—prostate cancer	0.000229	0.00168	CcSEcCtD
Perhexiline—Abdominal pain—Goserelin—prostate cancer	0.000227	0.00167	CcSEcCtD
Perhexiline—Muscular weakness—Prednisone—prostate cancer	0.000227	0.00167	CcSEcCtD
Perhexiline—Urticaria—Conjugated Estrogens—prostate cancer	0.000226	0.00167	CcSEcCtD
Perhexiline—Weight decreased—Capecitabine—prostate cancer	0.000226	0.00167	CcSEcCtD
Perhexiline—Neuropathy peripheral—Docetaxel—prostate cancer	0.000226	0.00166	CcSEcCtD
Perhexiline—Convulsion—Mitoxantrone—prostate cancer	0.000226	0.00166	CcSEcCtD
Perhexiline—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000225	0.00166	CcSEcCtD
Perhexiline—Shock—Estradiol—prostate cancer	0.000224	0.00165	CcSEcCtD
Perhexiline—Vomiting—Ethinyl Estradiol—prostate cancer	0.000222	0.00164	CcSEcCtD
Perhexiline—Hyperhidrosis—Estradiol—prostate cancer	0.00022	0.00162	CcSEcCtD
Perhexiline—Rash—Ethinyl Estradiol—prostate cancer	0.00022	0.00162	CcSEcCtD
Perhexiline—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00022	0.00162	CcSEcCtD
Perhexiline—Headache—Ethinyl Estradiol—prostate cancer	0.000219	0.00161	CcSEcCtD
Perhexiline—Neuropathy peripheral—Capecitabine—prostate cancer	0.000219	0.00161	CcSEcCtD
Perhexiline—Shock—Mitoxantrone—prostate cancer	0.000209	0.00154	CcSEcCtD
Perhexiline—Nausea—Ethinyl Estradiol—prostate cancer	0.000208	0.00153	CcSEcCtD
Perhexiline—Hepatitis—Docetaxel—prostate cancer	0.000207	0.00152	CcSEcCtD
Perhexiline—Hypoglycaemia—Epirubicin—prostate cancer	0.000207	0.00152	CcSEcCtD
Perhexiline—Asthenia—Goserelin—prostate cancer	0.000206	0.00152	CcSEcCtD
Perhexiline—Insomnia—Estradiol—prostate cancer	0.000206	0.00152	CcSEcCtD
Perhexiline—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000205	0.00151	CcSEcCtD
Perhexiline—Paraesthesia—Estradiol—prostate cancer	0.000205	0.00151	CcSEcCtD
Perhexiline—Asthenia—Conjugated Estrogens—prostate cancer	0.000204	0.00151	CcSEcCtD
Perhexiline—Anorexia—Mitoxantrone—prostate cancer	0.000203	0.00149	CcSEcCtD
Perhexiline—Diplopia—Epirubicin—prostate cancer	0.000202	0.00148	CcSEcCtD
Perhexiline—Weight decreased—Prednisone—prostate cancer	0.000202	0.00148	CcSEcCtD
Perhexiline—Hepatitis—Capecitabine—prostate cancer	0.0002	0.00147	CcSEcCtD
Perhexiline—Decreased appetite—Estradiol—prostate cancer	0.000198	0.00146	CcSEcCtD
Perhexiline—Fatigue—Estradiol—prostate cancer	0.000197	0.00145	CcSEcCtD
Perhexiline—Neuropathy peripheral—Prednisone—prostate cancer	0.000195	0.00143	CcSEcCtD
Perhexiline—Flushing—Docetaxel—prostate cancer	0.000192	0.00141	CcSEcCtD
Perhexiline—Hypoglycaemia—Doxorubicin—prostate cancer	0.000191	0.00141	CcSEcCtD
Perhexiline—Paraesthesia—Mitoxantrone—prostate cancer	0.000191	0.00141	CcSEcCtD
Perhexiline—Loss of consciousness—Etoposide—prostate cancer	0.00019	0.0014	CcSEcCtD
Perhexiline—Dizziness—Goserelin—prostate cancer	0.00019	0.0014	CcSEcCtD
Perhexiline—Ataxia—Epirubicin—prostate cancer	0.00019	0.0014	CcSEcCtD
Perhexiline—Dizziness—Conjugated Estrogens—prostate cancer	0.000188	0.00139	CcSEcCtD
Perhexiline—Convulsion—Etoposide—prostate cancer	0.000188	0.00138	CcSEcCtD
Perhexiline—Diplopia—Doxorubicin—prostate cancer	0.000187	0.00137	CcSEcCtD
Perhexiline—Gastrointestinal pain—Estradiol—prostate cancer	0.000187	0.00137	CcSEcCtD
Perhexiline—Flushing—Capecitabine—prostate cancer	0.000186	0.00137	CcSEcCtD
Perhexiline—Decreased appetite—Mitoxantrone—prostate cancer	0.000185	0.00136	CcSEcCtD
Perhexiline—Fatigue—Mitoxantrone—prostate cancer	0.000183	0.00135	CcSEcCtD
Perhexiline—Vomiting—Goserelin—prostate cancer	0.000183	0.00135	CcSEcCtD
Perhexiline—Rash—Goserelin—prostate cancer	0.000181	0.00134	CcSEcCtD
Perhexiline—Dermatitis—Goserelin—prostate cancer	0.000181	0.00133	CcSEcCtD
Perhexiline—Vomiting—Conjugated Estrogens—prostate cancer	0.000181	0.00133	CcSEcCtD
Perhexiline—Urticaria—Estradiol—prostate cancer	0.000181	0.00133	CcSEcCtD
Perhexiline—Abdominal pain—Estradiol—prostate cancer	0.00018	0.00133	CcSEcCtD
Perhexiline—Headache—Goserelin—prostate cancer	0.00018	0.00133	CcSEcCtD
Perhexiline—Rash—Conjugated Estrogens—prostate cancer	0.00018	0.00132	CcSEcCtD
Perhexiline—Dermatitis—Conjugated Estrogens—prostate cancer	0.00018	0.00132	CcSEcCtD
Perhexiline—Headache—Conjugated Estrogens—prostate cancer	0.000179	0.00131	CcSEcCtD
Perhexiline—Muscular weakness—Epirubicin—prostate cancer	0.000178	0.00131	CcSEcCtD
Perhexiline—Ataxia—Doxorubicin—prostate cancer	0.000175	0.00129	CcSEcCtD
Perhexiline—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000174	0.00128	CcSEcCtD
Perhexiline—Nausea—Goserelin—prostate cancer	0.000171	0.00126	CcSEcCtD
Perhexiline—Hyperhidrosis—Etoposide—prostate cancer	0.000171	0.00126	CcSEcCtD
Perhexiline—Nausea—Conjugated Estrogens—prostate cancer	0.000169	0.00125	CcSEcCtD
Perhexiline—Urticaria—Mitoxantrone—prostate cancer	0.000169	0.00124	CcSEcCtD
Perhexiline—Anorexia—Etoposide—prostate cancer	0.000169	0.00124	CcSEcCtD
Perhexiline—Abdominal pain—Mitoxantrone—prostate cancer	0.000168	0.00124	CcSEcCtD
Perhexiline—Flushing—Prednisone—prostate cancer	0.000166	0.00122	CcSEcCtD
Perhexiline—Muscular weakness—Doxorubicin—prostate cancer	0.000165	0.00121	CcSEcCtD
Perhexiline—Asthenia—Estradiol—prostate cancer	0.000164	0.0012	CcSEcCtD
Perhexiline—Tremor—Capecitabine—prostate cancer	0.000163	0.0012	CcSEcCtD
Perhexiline—Syncope—Docetaxel—prostate cancer	0.000161	0.00119	CcSEcCtD
Perhexiline—Paraesthesia—Etoposide—prostate cancer	0.000159	0.00117	CcSEcCtD
Perhexiline—Loss of consciousness—Docetaxel—prostate cancer	0.000158	0.00116	CcSEcCtD
Perhexiline—Weight decreased—Epirubicin—prostate cancer	0.000158	0.00116	CcSEcCtD
Perhexiline—Syncope—Capecitabine—prostate cancer	0.000156	0.00115	CcSEcCtD
Perhexiline—Convulsion—Docetaxel—prostate cancer	0.000156	0.00115	CcSEcCtD
Perhexiline—Decreased appetite—Etoposide—prostate cancer	0.000154	0.00113	CcSEcCtD
Perhexiline—Loss of consciousness—Capecitabine—prostate cancer	0.000153	0.00113	CcSEcCtD
Perhexiline—Asthenia—Mitoxantrone—prostate cancer	0.000152	0.00112	CcSEcCtD
Perhexiline—Fatigue—Etoposide—prostate cancer	0.000152	0.00112	CcSEcCtD
Perhexiline—Neuropathy peripheral—Epirubicin—prostate cancer	0.000152	0.00112	CcSEcCtD
Perhexiline—Dizziness—Estradiol—prostate cancer	0.000151	0.00111	CcSEcCtD
Perhexiline—Sweating—Epirubicin—prostate cancer	0.000149	0.0011	CcSEcCtD
Perhexiline—Weight decreased—Doxorubicin—prostate cancer	0.000146	0.00107	CcSEcCtD
Perhexiline—Vomiting—Estradiol—prostate cancer	0.000145	0.00107	CcSEcCtD
Perhexiline—Gastrointestinal pain—Etoposide—prostate cancer	0.000145	0.00106	CcSEcCtD
Perhexiline—Shock—Docetaxel—prostate cancer	0.000145	0.00106	CcSEcCtD
Perhexiline—Rash—Estradiol—prostate cancer	0.000144	0.00106	CcSEcCtD
Perhexiline—Dermatitis—Estradiol—prostate cancer	0.000144	0.00106	CcSEcCtD
Perhexiline—Headache—Estradiol—prostate cancer	0.000143	0.00105	CcSEcCtD
Perhexiline—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000141	0.00104	CcSEcCtD
Perhexiline—Urticaria—Etoposide—prostate cancer	0.00014	0.00103	CcSEcCtD
Perhexiline—Anorexia—Docetaxel—prostate cancer	0.00014	0.00103	CcSEcCtD
Perhexiline—Shock—Capecitabine—prostate cancer	0.00014	0.00103	CcSEcCtD
Perhexiline—Abdominal pain—Etoposide—prostate cancer	0.00014	0.00103	CcSEcCtD
Perhexiline—Hepatitis—Epirubicin—prostate cancer	0.000139	0.00103	CcSEcCtD
Perhexiline—Syncope—Prednisone—prostate cancer	0.000139	0.00103	CcSEcCtD
Perhexiline—Sweating—Doxorubicin—prostate cancer	0.000138	0.00101	CcSEcCtD
Perhexiline—Hyperhidrosis—Capecitabine—prostate cancer	0.000138	0.00101	CcSEcCtD
Perhexiline—Loss of consciousness—Prednisone—prostate cancer	0.000136	0.001	CcSEcCtD
Perhexiline—Anorexia—Capecitabine—prostate cancer	0.000136	0.000998	CcSEcCtD
Perhexiline—Nausea—Estradiol—prostate cancer	0.000135	0.000998	CcSEcCtD
Perhexiline—Vomiting—Mitoxantrone—prostate cancer	0.000135	0.000995	CcSEcCtD
Perhexiline—Convulsion—Prednisone—prostate cancer	0.000135	0.00099	CcSEcCtD
Perhexiline—Rash—Mitoxantrone—prostate cancer	0.000134	0.000987	CcSEcCtD
Perhexiline—Dermatitis—Mitoxantrone—prostate cancer	0.000134	0.000986	CcSEcCtD
Perhexiline—Headache—Mitoxantrone—prostate cancer	0.000133	0.00098	CcSEcCtD
Perhexiline—Insomnia—Docetaxel—prostate cancer	0.000133	0.000978	CcSEcCtD
Perhexiline—Paraesthesia—Docetaxel—prostate cancer	0.000132	0.000971	CcSEcCtD
Perhexiline—Flushing—Epirubicin—prostate cancer	0.000129	0.000953	CcSEcCtD
Perhexiline—Hepatitis—Doxorubicin—prostate cancer	0.000129	0.00095	CcSEcCtD
Perhexiline—Insomnia—Capecitabine—prostate cancer	0.000129	0.000947	CcSEcCtD
Perhexiline—Paraesthesia—Capecitabine—prostate cancer	0.000128	0.00094	CcSEcCtD
Perhexiline—Decreased appetite—Docetaxel—prostate cancer	0.000128	0.00094	CcSEcCtD
Perhexiline—Asthenia—Etoposide—prostate cancer	0.000127	0.000934	CcSEcCtD
Perhexiline—Fatigue—Docetaxel—prostate cancer	0.000127	0.000933	CcSEcCtD
Perhexiline—Nausea—Mitoxantrone—prostate cancer	0.000126	0.00093	CcSEcCtD
Perhexiline—Shock—Prednisone—prostate cancer	0.000125	0.000918	CcSEcCtD
Perhexiline—Decreased appetite—Capecitabine—prostate cancer	0.000124	0.00091	CcSEcCtD
Perhexiline—Fatigue—Capecitabine—prostate cancer	0.000123	0.000903	CcSEcCtD
Perhexiline—Hyperhidrosis—Prednisone—prostate cancer	0.000122	0.000902	CcSEcCtD
Perhexiline—Anorexia—Prednisone—prostate cancer	0.000121	0.000889	CcSEcCtD
Perhexiline—Gastrointestinal pain—Docetaxel—prostate cancer	0.00012	0.000885	CcSEcCtD
Perhexiline—Flushing—Doxorubicin—prostate cancer	0.00012	0.000882	CcSEcCtD
Perhexiline—Tension—Epirubicin—prostate cancer	0.000119	0.000877	CcSEcCtD
Perhexiline—Nervousness—Epirubicin—prostate cancer	0.000118	0.000868	CcSEcCtD
Perhexiline—Dizziness—Etoposide—prostate cancer	0.000117	0.000861	CcSEcCtD
Perhexiline—Gastrointestinal pain—Capecitabine—prostate cancer	0.000116	0.000856	CcSEcCtD
Perhexiline—Abdominal pain—Docetaxel—prostate cancer	0.000116	0.000855	CcSEcCtD
Perhexiline—Insomnia—Prednisone—prostate cancer	0.000115	0.000844	CcSEcCtD
Perhexiline—Paraesthesia—Prednisone—prostate cancer	0.000114	0.000838	CcSEcCtD
Perhexiline—Urticaria—Capecitabine—prostate cancer	0.000113	0.000832	CcSEcCtD
Perhexiline—Abdominal pain—Capecitabine—prostate cancer	0.000112	0.000828	CcSEcCtD
Perhexiline—Vomiting—Etoposide—prostate cancer	0.000112	0.000828	CcSEcCtD
Perhexiline—Rash—Etoposide—prostate cancer	0.000111	0.000821	CcSEcCtD
Perhexiline—Dermatitis—Etoposide—prostate cancer	0.000111	0.00082	CcSEcCtD
Perhexiline—Headache—Etoposide—prostate cancer	0.000111	0.000815	CcSEcCtD
Perhexiline—Tension—Doxorubicin—prostate cancer	0.00011	0.000812	CcSEcCtD
Perhexiline—Decreased appetite—Prednisone—prostate cancer	0.00011	0.000811	CcSEcCtD
Perhexiline—Fatigue—Prednisone—prostate cancer	0.000109	0.000804	CcSEcCtD
Perhexiline—Nervousness—Doxorubicin—prostate cancer	0.000109	0.000803	CcSEcCtD
Perhexiline—Syncope—Epirubicin—prostate cancer	0.000109	0.000802	CcSEcCtD
Perhexiline—Loss of consciousness—Epirubicin—prostate cancer	0.000107	0.000786	CcSEcCtD
Perhexiline—Asthenia—Docetaxel—prostate cancer	0.000105	0.000776	CcSEcCtD
Perhexiline—Convulsion—Epirubicin—prostate cancer	0.000105	0.000775	CcSEcCtD
Perhexiline—Nausea—Etoposide—prostate cancer	0.000105	0.000773	CcSEcCtD
Perhexiline—Gastrointestinal pain—Prednisone—prostate cancer	0.000104	0.000763	CcSEcCtD
Perhexiline—Asthenia—Capecitabine—prostate cancer	0.000102	0.000751	CcSEcCtD
Perhexiline—Syncope—Doxorubicin—prostate cancer	0.000101	0.000742	CcSEcCtD
Perhexiline—Urticaria—Prednisone—prostate cancer	0.000101	0.000741	CcSEcCtD
Perhexiline—Abdominal pain—Prednisone—prostate cancer	0.0001	0.000737	CcSEcCtD
Perhexiline—Loss of consciousness—Doxorubicin—prostate cancer	9.87e-05	0.000727	CcSEcCtD
Perhexiline—Shock—Epirubicin—prostate cancer	9.75e-05	0.000718	CcSEcCtD
Perhexiline—Convulsion—Doxorubicin—prostate cancer	9.73e-05	0.000717	CcSEcCtD
Perhexiline—Dizziness—Docetaxel—prostate cancer	9.71e-05	0.000715	CcSEcCtD
Perhexiline—Hyperhidrosis—Epirubicin—prostate cancer	9.58e-05	0.000705	CcSEcCtD
Perhexiline—Anorexia—Epirubicin—prostate cancer	9.45e-05	0.000695	CcSEcCtD
Perhexiline—Dizziness—Capecitabine—prostate cancer	9.41e-05	0.000693	CcSEcCtD
Perhexiline—Vomiting—Docetaxel—prostate cancer	9.34e-05	0.000688	CcSEcCtD
Perhexiline—Rash—Docetaxel—prostate cancer	9.26e-05	0.000682	CcSEcCtD
Perhexiline—Dermatitis—Docetaxel—prostate cancer	9.25e-05	0.000681	CcSEcCtD
Perhexiline—Headache—Docetaxel—prostate cancer	9.2e-05	0.000678	CcSEcCtD
Perhexiline—Asthenia—Prednisone—prostate cancer	9.09e-05	0.000669	CcSEcCtD
Perhexiline—Vomiting—Capecitabine—prostate cancer	9.04e-05	0.000666	CcSEcCtD
Perhexiline—Shock—Doxorubicin—prostate cancer	9.02e-05	0.000664	CcSEcCtD
Perhexiline—Rash—Capecitabine—prostate cancer	8.97e-05	0.00066	CcSEcCtD
Perhexiline—Insomnia—Epirubicin—prostate cancer	8.96e-05	0.00066	CcSEcCtD
Perhexiline—Dermatitis—Capecitabine—prostate cancer	8.96e-05	0.00066	CcSEcCtD
Perhexiline—Headache—Capecitabine—prostate cancer	8.91e-05	0.000656	CcSEcCtD
Perhexiline—Paraesthesia—Epirubicin—prostate cancer	8.9e-05	0.000655	CcSEcCtD
Perhexiline—Hyperhidrosis—Doxorubicin—prostate cancer	8.86e-05	0.000653	CcSEcCtD
Perhexiline—Anorexia—Doxorubicin—prostate cancer	8.74e-05	0.000644	CcSEcCtD
Perhexiline—Nausea—Docetaxel—prostate cancer	8.73e-05	0.000643	CcSEcCtD
Perhexiline—Decreased appetite—Epirubicin—prostate cancer	8.61e-05	0.000634	CcSEcCtD
Perhexiline—Fatigue—Epirubicin—prostate cancer	8.54e-05	0.000629	CcSEcCtD
Perhexiline—Nausea—Capecitabine—prostate cancer	8.45e-05	0.000622	CcSEcCtD
Perhexiline—Dizziness—Prednisone—prostate cancer	8.38e-05	0.000617	CcSEcCtD
Perhexiline—Insomnia—Doxorubicin—prostate cancer	8.29e-05	0.000611	CcSEcCtD
Perhexiline—Paraesthesia—Doxorubicin—prostate cancer	8.23e-05	0.000606	CcSEcCtD
Perhexiline—Gastrointestinal pain—Epirubicin—prostate cancer	8.1e-05	0.000597	CcSEcCtD
Perhexiline—Vomiting—Prednisone—prostate cancer	8.06e-05	0.000593	CcSEcCtD
Perhexiline—Rash—Prednisone—prostate cancer	7.99e-05	0.000588	CcSEcCtD
Perhexiline—Dermatitis—Prednisone—prostate cancer	7.98e-05	0.000588	CcSEcCtD
Perhexiline—Decreased appetite—Doxorubicin—prostate cancer	7.97e-05	0.000587	CcSEcCtD
Perhexiline—Headache—Prednisone—prostate cancer	7.94e-05	0.000584	CcSEcCtD
Perhexiline—Fatigue—Doxorubicin—prostate cancer	7.9e-05	0.000582	CcSEcCtD
Perhexiline—Urticaria—Epirubicin—prostate cancer	7.87e-05	0.00058	CcSEcCtD
Perhexiline—Abdominal pain—Epirubicin—prostate cancer	7.83e-05	0.000577	CcSEcCtD
Perhexiline—Nausea—Prednisone—prostate cancer	7.53e-05	0.000554	CcSEcCtD
Perhexiline—Gastrointestinal pain—Doxorubicin—prostate cancer	7.5e-05	0.000552	CcSEcCtD
Perhexiline—Urticaria—Doxorubicin—prostate cancer	7.28e-05	0.000536	CcSEcCtD
Perhexiline—Abdominal pain—Doxorubicin—prostate cancer	7.25e-05	0.000534	CcSEcCtD
Perhexiline—Asthenia—Epirubicin—prostate cancer	7.11e-05	0.000523	CcSEcCtD
Perhexiline—Asthenia—Doxorubicin—prostate cancer	6.58e-05	0.000484	CcSEcCtD
Perhexiline—Dizziness—Epirubicin—prostate cancer	6.55e-05	0.000482	CcSEcCtD
Perhexiline—Vomiting—Epirubicin—prostate cancer	6.3e-05	0.000464	CcSEcCtD
Perhexiline—Rash—Epirubicin—prostate cancer	6.25e-05	0.00046	CcSEcCtD
Perhexiline—Dermatitis—Epirubicin—prostate cancer	6.24e-05	0.00046	CcSEcCtD
Perhexiline—Headache—Epirubicin—prostate cancer	6.21e-05	0.000457	CcSEcCtD
Perhexiline—Dizziness—Doxorubicin—prostate cancer	6.06e-05	0.000446	CcSEcCtD
Perhexiline—Nausea—Epirubicin—prostate cancer	5.89e-05	0.000433	CcSEcCtD
Perhexiline—Vomiting—Doxorubicin—prostate cancer	5.83e-05	0.000429	CcSEcCtD
Perhexiline—Rash—Doxorubicin—prostate cancer	5.78e-05	0.000426	CcSEcCtD
Perhexiline—Dermatitis—Doxorubicin—prostate cancer	5.78e-05	0.000425	CcSEcCtD
Perhexiline—Headache—Doxorubicin—prostate cancer	5.74e-05	0.000423	CcSEcCtD
Perhexiline—Nausea—Doxorubicin—prostate cancer	5.45e-05	0.000401	CcSEcCtD
Perhexiline—CYP2B6—Metabolism—TCN2—prostate cancer	1.4e-05	9.17e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTA3—prostate cancer	1.4e-05	9.17e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—UCP3—prostate cancer	1.4e-05	9.17e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HSD3B1—prostate cancer	1.33e-05	8.75e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC22A3—prostate cancer	1.33e-05	8.75e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HPGD—prostate cancer	1.28e-05	8.41e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—B4GALT4—prostate cancer	1.28e-05	8.41e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTA4—prostate cancer	1.28e-05	8.39e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TBXAS1—prostate cancer	1.28e-05	8.39e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTA2—prostate cancer	1.24e-05	8.17e-05	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—prostate cancer	1.24e-05	8.14e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCG5—prostate cancer	1.23e-05	8.07e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SULT1A1—prostate cancer	1.23e-05	8.07e-05	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTEN—prostate cancer	1.22e-05	8e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TNFRSF21—prostate cancer	1.2e-05	7.91e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTA1—prostate cancer	1.2e-05	7.88e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PSAT1—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GRHL1—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CBR1—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TST—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CSAD—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ADI1—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HSD3B2—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NAT2—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTO1—prostate cancer	1.19e-05	7.8e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP7B1—prostate cancer	1.17e-05	7.69e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTAP—prostate cancer	1.17e-05	7.69e-05	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—EP300—prostate cancer	1.16e-05	7.63e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SULT1E1—prostate cancer	1.14e-05	7.49e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SRD5A1—prostate cancer	1.14e-05	7.49e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PLCB2—prostate cancer	1.14e-05	7.47e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP2C18—prostate cancer	1.14e-05	7.47e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—LRP2—prostate cancer	1.14e-05	7.47e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—P4HB—prostate cancer	1.12e-05	7.33e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.1e-05	7.25e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.1e-05	7.25e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GRHPR—prostate cancer	1.1e-05	7.25e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CKMT2—prostate cancer	1.1e-05	7.25e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ACSL4—prostate cancer	1.09e-05	7.15e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HSD17B3—prostate cancer	1.09e-05	7.15e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC22A1—prostate cancer	1.09e-05	7.13e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SULT2A1—prostate cancer	1.06e-05	6.95e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PHGDH—prostate cancer	1.04e-05	6.85e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—UMPS—prostate cancer	1.04e-05	6.85e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ARG2—prostate cancer	1.04e-05	6.85e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MED12—prostate cancer	1.04e-05	6.84e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AOX1—prostate cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—RFK—prostate cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NAGLU—prostate cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PGAM2—prostate cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTM3—prostate cancer	1.04e-05	6.82e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GNG5—prostate cancer	1.03e-05	6.78e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—LDHB—prostate cancer	1.02e-05	6.72e-05	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKT1—prostate cancer	1.01e-05	6.65e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP3A5—prostate cancer	1e-05	6.6e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NCOA3—prostate cancer	9.95e-06	6.53e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP3A43—prostate cancer	9.85e-06	6.47e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AMACR—prostate cancer	9.85e-06	6.47e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SRD5A2—prostate cancer	9.85e-06	6.47e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NAT1—prostate cancer	9.85e-06	6.47e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—DEGS1—prostate cancer	9.85e-06	6.47e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PDHA1—prostate cancer	9.7e-06	6.37e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TCN2—prostate cancer	9.7e-06	6.37e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—UCP3—prostate cancer	9.7e-06	6.37e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTA3—prostate cancer	9.7e-06	6.37e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HPGDS—prostate cancer	9.49e-06	6.23e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP2C19—prostate cancer	9.43e-06	6.19e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.39e-06	6.17e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC22A3—prostate cancer	9.26e-06	6.08e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HSD3B1—prostate cancer	9.26e-06	6.08e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTT1—prostate cancer	9.2e-06	6.05e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ACHE—prostate cancer	9.2e-06	6.05e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP2A6—prostate cancer	9.1e-06	5.98e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TBXAS1—prostate cancer	8.87e-06	5.83e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTA4—prostate cancer	8.87e-06	5.83e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKR1C3—prostate cancer	8.85e-06	5.81e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PRKACB—prostate cancer	8.8e-06	5.78e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP17A1—prostate cancer	8.71e-06	5.72e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTA2—prostate cancer	8.65e-06	5.68e-05	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—prostate cancer	8.59e-06	5.64e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SULT1A1—prostate cancer	8.54e-06	5.61e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCG5—prostate cancer	8.54e-06	5.61e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HPGD—prostate cancer	8.37e-06	5.5e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.37e-06	5.5e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTA1—prostate cancer	8.34e-06	5.48e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NCOA2—prostate cancer	8.3e-06	5.45e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NAT2—prostate cancer	8.25e-06	5.42e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HSD3B2—prostate cancer	8.25e-06	5.42e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTO1—prostate cancer	8.25e-06	5.42e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC5A5—prostate cancer	7.92e-06	5.2e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PLCB2—prostate cancer	7.91e-06	5.19e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—LRP2—prostate cancer	7.91e-06	5.19e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP2C18—prostate cancer	7.91e-06	5.19e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TNFRSF21—prostate cancer	7.87e-06	5.17e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—P4HB—prostate cancer	7.76e-06	5.09e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP2E1—prostate cancer	7.74e-06	5.08e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.66e-06	5.03e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTAP—prostate cancer	7.66e-06	5.03e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NQO1—prostate cancer	7.65e-06	5.02e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC22A1—prostate cancer	7.55e-06	4.96e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TH—prostate cancer	7.54e-06	4.95e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.46e-06	4.9e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.46e-06	4.9e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP3A4—prostate cancer	7.46e-06	4.9e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SULT2A1—prostate cancer	7.35e-06	4.83e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP1B1—prostate cancer	7.33e-06	4.82e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MED12—prostate cancer	7.23e-06	4.75e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GNG5—prostate cancer	7.18e-06	4.71e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.12e-06	4.67e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ACSL4—prostate cancer	7.12e-06	4.67e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GGT1—prostate cancer	7.1e-06	4.66e-05	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKT1—prostate cancer	7.02e-06	4.61e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NCOA1—prostate cancer	7e-06	4.59e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NCOA3—prostate cancer	6.91e-06	4.54e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP19A1—prostate cancer	6.9e-06	4.53e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PHGDH—prostate cancer	6.82e-06	4.48e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—UMPS—prostate cancer	6.82e-06	4.48e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ARG2—prostate cancer	6.82e-06	4.48e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—LDHB—prostate cancer	6.69e-06	4.4e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—RXRA—prostate cancer	6.65e-06	4.37e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HPGDS—prostate cancer	6.6e-06	4.33e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.57e-06	4.31e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP2C19—prostate cancer	6.55e-06	4.3e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—COMT—prostate cancer	6.41e-06	4.21e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTT1—prostate cancer	6.4e-06	4.2e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ACHE—prostate cancer	6.4e-06	4.2e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTP1—prostate cancer	6.38e-06	4.19e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PDHA1—prostate cancer	6.34e-06	4.17e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTA3—prostate cancer	6.34e-06	4.17e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—UCP3—prostate cancer	6.34e-06	4.17e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TCN2—prostate cancer	6.34e-06	4.17e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP2A6—prostate cancer	6.32e-06	4.15e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ITPR1—prostate cancer	6.28e-06	4.12e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKR1C3—prostate cancer	6.15e-06	4.04e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PRKACB—prostate cancer	6.12e-06	4.02e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP17A1—prostate cancer	6.06e-06	3.98e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.05e-06	3.97e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.05e-06	3.97e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TYMS—prostate cancer	5.93e-06	3.9e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTM1—prostate cancer	5.86e-06	3.85e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTA4—prostate cancer	5.8e-06	3.81e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.8e-06	3.81e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NCOA2—prostate cancer	5.77e-06	3.79e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—LPL—prostate cancer	5.75e-06	3.78e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTA2—prostate cancer	5.65e-06	3.71e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCG5—prostate cancer	5.59e-06	3.67e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.59e-06	3.67e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP1A1—prostate cancer	5.56e-06	3.65e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ERCC2—prostate cancer	5.51e-06	3.62e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.5e-06	3.62e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTA1—prostate cancer	5.46e-06	3.58e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NAT2—prostate cancer	5.39e-06	3.54e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTO1—prostate cancer	5.39e-06	3.54e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.39e-06	3.54e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP2E1—prostate cancer	5.38e-06	3.53e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NQO1—prostate cancer	5.32e-06	3.49e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TH—prostate cancer	5.24e-06	3.44e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP3A4—prostate cancer	5.18e-06	3.41e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—MTHFR—prostate cancer	5.18e-06	3.4e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PLCB2—prostate cancer	5.17e-06	3.4e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—LRP2—prostate cancer	5.17e-06	3.4e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.17e-06	3.4e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP1B1—prostate cancer	5.1e-06	3.35e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPARA—prostate cancer	5.08e-06	3.34e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—P4HB—prostate cancer	5.07e-06	3.33e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GGT1—prostate cancer	4.94e-06	3.24e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.93e-06	3.24e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NCOA1—prostate cancer	4.86e-06	3.19e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.81e-06	3.16e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.79e-06	3.15e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CAV1—prostate cancer	4.78e-06	3.14e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MED12—prostate cancer	4.73e-06	3.11e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GNG5—prostate cancer	4.69e-06	3.08e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—RXRA—prostate cancer	4.63e-06	3.04e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NCOA3—prostate cancer	4.52e-06	2.97e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—COMT—prostate cancer	4.46e-06	2.93e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTP1—prostate cancer	4.43e-06	2.91e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ITPR1—prostate cancer	4.36e-06	2.87e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CG—prostate cancer	4.35e-06	2.86e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HPGDS—prostate cancer	4.31e-06	2.83e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.29e-06	2.81e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTT1—prostate cancer	4.18e-06	2.75e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ACHE—prostate cancer	4.18e-06	2.75e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.13e-06	2.72e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TYMS—prostate cancer	4.12e-06	2.71e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—INS—prostate cancer	4.12e-06	2.71e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTM1—prostate cancer	4.07e-06	2.68e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CREBBP—prostate cancer	4.04e-06	2.65e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.02e-06	2.64e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PRKACB—prostate cancer	4e-06	2.63e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—LPL—prostate cancer	4e-06	2.63e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.96e-06	2.6e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.86e-06	2.54e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ERCC2—prostate cancer	3.83e-06	2.52e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CD—prostate cancer	3.83e-06	2.51e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NCOA2—prostate cancer	3.77e-06	2.48e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NOS3—prostate cancer	3.61e-06	2.37e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—MTHFR—prostate cancer	3.6e-06	2.37e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.6e-06	2.36e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPARA—prostate cancer	3.53e-06	2.32e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.52e-06	2.31e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NQO1—prostate cancer	3.48e-06	2.28e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TH—prostate cancer	3.43e-06	2.25e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CB—prostate cancer	3.34e-06	2.19e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.33e-06	2.19e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CAV1—prostate cancer	3.32e-06	2.18e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—prostate cancer	3.31e-06	2.17e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GGT1—prostate cancer	3.23e-06	2.12e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NCOA1—prostate cancer	3.18e-06	2.09e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.13e-06	2.06e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.03e-06	1.99e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—RXRA—prostate cancer	3.02e-06	1.99e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—COMT—prostate cancer	2.91e-06	1.91e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTP1—prostate cancer	2.9e-06	1.9e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTEN—prostate cancer	2.88e-06	1.89e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—INS—prostate cancer	2.86e-06	1.88e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ITPR1—prostate cancer	2.85e-06	1.87e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CREBBP—prostate cancer	2.81e-06	1.84e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—EP300—prostate cancer	2.75e-06	1.81e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TYMS—prostate cancer	2.7e-06	1.77e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTM1—prostate cancer	2.66e-06	1.75e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.66e-06	1.75e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—LPL—prostate cancer	2.62e-06	1.72e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.53e-06	1.66e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NOS3—prostate cancer	2.51e-06	1.65e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ERCC2—prostate cancer	2.5e-06	1.65e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—MTHFR—prostate cancer	2.35e-06	1.55e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.32e-06	1.52e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPARA—prostate cancer	2.31e-06	1.52e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—prostate cancer	2.3e-06	1.51e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CAV1—prostate cancer	2.17e-06	1.43e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—prostate cancer	2.03e-06	1.34e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTEN—prostate cancer	2e-06	1.32e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.98e-06	1.3e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—EP300—prostate cancer	1.91e-06	1.25e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—INS—prostate cancer	1.87e-06	1.23e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CREBBP—prostate cancer	1.83e-06	1.2e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.74e-06	1.14e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKT1—prostate cancer	1.66e-06	1.09e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NOS3—prostate cancer	1.64e-06	1.08e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.52e-06	9.96e-06	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—prostate cancer	1.5e-06	9.86e-06	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.41e-06	9.28e-06	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTEN—prostate cancer	1.31e-06	8.6e-06	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—EP300—prostate cancer	1.25e-06	8.2e-06	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKT1—prostate cancer	1.15e-06	7.58e-06	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.24e-07	6.07e-06	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKT1—prostate cancer	7.55e-07	4.96e-06	CbGpPWpGaD
